Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P)+ transhydrogenase enzyme

US11041176B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11041176-B2
Application numberUS-201715816779-A
CountryUS
Kind codeB2
Filing dateNov 17, 2017
Priority dateJul 25, 2012
Publication dateJun 22, 2021
Grant dateJun 22, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.

First claim

Opening claim text (preview).

The invention claimed is: 1. A fermentation broth comprising at least one carbon source and recombinant yeast cells engineered to produce succinate through an active reductive tricarboxylic acid (TCA) pathway from pyruvate or phosphoenolpyruvate, wherein the recombinant yeast cells are genetically modified to express a soluble nicotinamide adenine dinucleotide phosphate (NAD(P)+) transhydrogenase enzyme in the cytosol of the yeast cells by having integrated into their genomes an exogenous gene encoding the soluble NAD(P)+ transhydrogenase enzyme, wherein the recombinant yeast cells are further modified by having integrated into their genomes at least one of: (i) an exogenous pyruvate carboxylase gene that encodes an enzyme which catalyzes the conversion of pyruvate to oxaloacetate; (ii) an exogenous malate dehydrogenase gene which encodes an enzyme that catalyzes the conversion of oxaloacetate to malate; (iii) an exogenous fumarase gene that encodes an enzyme which catalyzes the conversion of malate to fumarate; and (iv) an exogenous fumarate reductase gene which encodes an enzyme which catalyzes the conversion of fumarate to succinate, and wherein the recombinant yeast cells produce more succinate through the active reductive TCA pathway as compared to a corresponding parent yeast cell lacking the soluble NAD(P)+ transhydrogenase enzyme.

Assignees

Inventors

Classifications

  • Genes encoding for enzymes or proenzymes · CPC title

  • Fuel from waste, e.g. synthetic alcohol or diesel · CPC title

  • with NAD+ or NADP+ as acceptor (1.1.1) · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • NAD(P)+ transhydrogenase (B-specific) (1.6.1.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11041176B2 cover?
Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.
Who is the assignee on this patent?
Cargill Inc
What technology area does this patent fall under?
Primary CPC classification C12P7/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).